P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA

P-009: IDENTIFYING BARRIERS FOR PATIENTS WITH SICKLE CELL DISEASE TO ACCESS TREATMENT WITH HYDROXYUREA – A QUALITATIVE ANALYSIS OF THE SUPPLY CHAIN IN GHANA

Bibliographic Details
Main Authors:	GRAVEN S., MARFO K., KARIM A., BISCHOF A., GEISSLER A.
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000872940.76494.9b

Similar Items

S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA
by: K Ohene-Frempong, et al.
Published: (2022-01-01)

Hydroxyurea Treatment for Sickle Cell Disease
by: Martin H. Steinberg
Published: (2002-01-01)

Hydroxyurea and sickle cell anemia: effect on quality of life
by: Pegelow Charles H, et al.
Published: (2006-08-01)

Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01)

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
by: Mohammed Ali Madkhali, et al.
Published: (2024-01-01)

Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania
by: Ambrose EE, et al.
Published: (2023-01-01)

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania
by: Manase Kilonzi, et al.
Published: (2021-11-01)

P1489: MANAGEMENT OF SICKLE CELL DISEASE WITH HYDROXYUREA: A SYSTEMATIC REVIEW FROM LOW- AND MIDDLE-INCOME COUNTRIES
by: V. Paintsil, et al.
Published: (2022-06-01)

The modern use of hydroxyurea for children with sickle cell anemia
by: Charles T. Quinn, et al.
Published: (2025-01-01)

Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease
by: Daniela Di Grazia, et al.
Published: (2024-10-01)

Adhesion molecules and hydroxyurea in the pathophysiology of sickle cell disease
by: Clarissa Johnson, et al.
Published: (2008-04-01)

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015-03-01)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
by: Emanuel Almeida Moreira de Oliveira, et al.

Hydroxyurea granules for the management of sickle cell disease in children
by: Grace Lovia Allotey-Babington, et al.
Published: (2022-07-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

P-007: HYDROXYUREA FOR THE MANAGEMENT OF SICKLE CELL DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW (2000–2022)
by: TSHILOLO L., et al.
Published: (2022-08-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Qualitative Analysis of Hydroxyurea
by: Stéfanno Souza Santos, et al.
Published: (2020-07-01)

Cellular biophysical markers of hydroxyurea treatment in sickle cell disease
by: Du, E., et al.
Published: (2018)

Influence of hydroxyurea on tubular phosphate handling in sickle cell nephropathy
by: Gabriela Araujo de Abreu, et al.
Published: (2024-11-01)

Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
by: Mohammed Ali Al Sabbah, et al.
Published: (2023-07-01)

Evaluation of pediatric hydroxyurea prescriptions for patients with sickle cell disease
by: Fernanda Alice Tanimoto Duque, et al.
Published: (2022-11-01)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022-05-01)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
by: Paul Lumbala Kabuyi, et al.
Published: (2023-08-01)

Determining of the Hydroxyurea Effluence on TCD Parameters of Sickle Cell Patients
by: Nasser Sharafadinzadeh, et al.
Published: (2009-07-01)

Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
by: Khayat André Salim, et al.
Published: (2004-01-01)

EVALUATION OF THE LEUKOCYTE INDEX IN SICKLE CELL ANEMIA WITH THE USE OF HYDROXYUREA
by: JO Rios, et al.
Published: (2021-10-01)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
by: Eduard Johannes van Beers, et al.
Published: (2012-01-01)

Hydroxyurea maintains working memory function in pediatric sickle cell disease.
by: Jesyin Lai, et al.
Published: (2024-01-01)

Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program.
by: Kerri A Nottage, et al.
Published: (2013-01-01)

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease
by: Hosseini, Poorya, et al.
Published: (2018)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia
by: Rhiannon R. Penkert, et al.
Published: (2018-02-01)

Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient
by: Mayur S. Dudhe, et al.
Published: (2023-11-01)

Hydroxyurea utilization and dose optimization in children with sickle cell disease (SCD)
by: Nour Alotaibi, et al.
Published: (2023-01-01)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
by: Dhiraj Kumar Yadav, et al.
Published: (2020-07-01)